Published in Drug Alcohol Depend on December 01, 1995
Adolescent cannabis problems and young adult depression: male-female stratified propensity score analyses. Am J Epidemiol (2008) 1.63
Epidemiological estimates of risk in the process of becoming dependent upon cocaine: cocaine hydrochloride powder versus crack cocaine. Psychopharmacology (Berl) (2003) 1.53
Self-report of Longitudinal Substance Use: A Comparison of the UCLA Natural History Interview and the Addiction Severity Index. J Drug Issues (2010) 1.18
Negative emotions and alcohol use initiation in high-risk boys: the moderating effect of good inhibitory control. J Abnorm Child Psychol (2004) 1.10
High-risk behaviors after release from incarceration among people who inject drugs in St. Petersburg, Russia. Drug Alcohol Depend (2014) 0.89
Predictors of methamphetamine injection in out-of-treatment IDUs. Subst Use Misuse (2009) 0.85
Does treatment readiness enhance the response of African American substance users to Motivational Enhancement Therapy? Psychol Addict Behav (2013) 0.81
Sex differences in drug use among polysubstance users. Drug Alcohol Depend (2014) 0.81
Depressive and anxiety symptomatology in ecstasy users: the relative contribution of genes, trauma, life stress and drug use. Psychopharmacology (Berl) (2010) 0.80
Consistency in Self-Reports of Drug Use Frequency by High-Risk Offenders Over a 5-Year Interval. Prison J (2013) 0.76
Consistency of self-reported drug use events in a mixed methods study of people who inject drugs. Am J Drug Alcohol Abuse (2015) 0.75
Smoking, smoking cessation, and major depression. JAMA (1990) 5.89
Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry (2008) 4.70
Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN. Drug Alcohol Depend (1997) 3.95
Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol (1986) 3.34
The reliability of the CIDI-SAM: a comprehensive substance abuse interview. Br J Addict (1989) 3.32
Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The Multicentre WHO/ADAMHA Field Trials. Br J Psychiatry (1991) 3.32
Taking chances: problem gamblers and mental health disorders--results from the St. Louis Epidemiologic Catchment Area Study. Am J Public Health (1998) 3.08
Concordance between ICD-10 alcohol and drug use disorder criteria and diagnoses as measured by the AUDADIS-ADR, CIDI and SCAN: results of a cross-national study. Drug Alcohol Depend (1997) 2.99
Achieving a 96.6 percent follow-up rate in a longitudinal study of drug abusers. Drug Alcohol Depend (1996) 2.76
Posttraumatic stress disorder among substance users from the general population. Am J Psychiatry (1992) 2.61
Difficult-to-recruit respondents and their effect on prevalence estimates in an epidemiologic survey. Am J Epidemiol (1987) 2.51
Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol (1999) 2.07
Childhood victimization and drug abuse: a comparison of prospective and retrospective findings. J Consult Clin Psychol (1999) 1.91
Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men. J Urol (1998) 1.80
Impact of first-line vs second-line antibiotics for the treatment of acute uncomplicated sinusitis. JAMA (2001) 1.71
A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol (2000) 1.69
Peer-delivered interventions reduce HIV risk behaviors among out-of-treatment drug abusers. Public Health Rep (1998) 1.55
Comparing assessments of DSM-IV substance dependence disorders using CIDI-SAM and SCAN. Drug Alcohol Depend (1996) 1.54
Assaults by patients on psychiatric residents at three training sites. Hosp Community Psychiatry (1994) 1.52
Is there a relationship between "heavy drinking" and HIV high risk sexual behaviors among general population subjects? Int J Addict (1995) 1.44
Substance dependence and other psychiatric disorders among drug dependent subjects: race and gender correlates. Am J Addict (2000) 1.36
Reliability of substance use disorder diagnoses among African-Americans and Caucasians. Drug Alcohol Depend (2000) 1.34
Inhalant use among urban American Indian youth. Addiction (1999) 1.34
Psychiatric disorders among drug dependent subjects: are they primary or secondary? Am J Addict (2000) 1.30
Problem gambling and comorbid psychiatric and substance use disorders among drug users recruited from drug treatment and community settings. J Gambl Stud (2000) 1.28
The epidemiology of pathological gambling. Semin Clin Neuropsychiatry (2001) 1.25
Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther (2007) 1.25
Gender differences in risk factors for trauma exposure and post-traumatic stress disorder among inner-city drug abusers in and out of treatment. Compr Psychiatry (2001) 1.23
Effectiveness of HIV risk reduction initiatives among out-of-treatment non-injection drug users. J Psychoactive Drugs (1999) 1.17
Legal needle buying in St. Louis. Am J Public Health (1992) 1.11
Reaching and enrolling drug users for HIV prevention: a multi-site analysis. Drug Alcohol Depend (1999) 1.05
Agreement between DSM-III and III-R substance use disorders. Drug Alcohol Depend (1991) 1.04
Subtypes of adult antisocial behavior among drug abusers. J Nerv Ment Dis (1995) 1.04
HIV prevention protocols: adaptation to evolving trends in drug use. J Psychoactive Drugs (1999) 1.04
The Diagnostic Interview Schedule for Children (PC-DISC v.3.0): parents and adolescents suggest reasons for expecting discrepant answers. J Abnorm Child Psychol (1995) 0.99
Clinical observation of assessment using the Composite International Diagnostic Interview (CIDI). An analysis of the CIDI Field Trials--Wave II at the St Louis site. Br J Psychiatry (1992) 0.98
Semi-mechanistic population pharmacokinetic model of multivalent trastuzumab emtansine in patients with metastatic breast cancer. Clin Pharmacol Ther (2012) 0.98
Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng./ml. or less. J Urol (1999) 0.97
Severity of dependence: data from the DSM-IV field trials. Addiction (1993) 0.97
Network-based approaches in drug discovery and early development. Clin Pharmacol Ther (2013) 0.94
Population pharmacokinetics and dose optimization of mycophenolic acid in HCT recipients receiving oral mycophenolate mofetil. J Clin Pharmacol (2013) 0.93
A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer. Cancer Chemother Pharmacol (2006) 0.90
Bridging Clinical Outcomes of Canakinumab Treatment in Patients With Rheumatoid Arthritis With a Population Model of IL-1β Kinetics. CPT Pharmacometrics Syst Pharmacol (2012) 0.89
Is antisocial personality disorder associated with increased HIV risk behaviors in cocaine users? Drug Alcohol Depend (1995) 0.89
Pharmacokinetics and metabolism of (R,R)-methoxyfenoterol in rat. Xenobiotica (2010) 0.88
Diagnostic concordance of DSM-III-R, DSM-IV, and ICD-10 inhalant use disorders. Drug Alcohol Depend (2001) 0.88
The effects of psychiatric comorbidity on response to an HIV prevention intervention. Drug Alcohol Depend (2000) 0.87
The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels. J Urol (1999) 0.85
Correlates of dissatisfaction with treatment in patients with prostate cancer diagnosed through screening. J Urol (1999) 0.85
Alcohol abuse and dependence: consistency in reporting of symptoms over ten years. Addiction (1995) 0.84
Clinical and pathological characteristics, and recurrence rates of stage T1c versus T2a or T2b prostate cancer. J Urol (1999) 0.84
What incentives are effective rewards for 'hidden populations' interviewed as a part of research projects? Public Health Rep (1995) 0.83
Reliability of self-reported antisocial personality disorder symptoms among substance abusers. Drug Alcohol Depend (1998) 0.83
Gender and race matching preferences for HIV post-test counselling in an African-American sample. AIDS Care (2006) 0.81
Cocaine users with antisocial personality improve HIV risk behaviors as much as those without antisocial personality. Drug Alcohol Depend (1998) 0.80
Pharmacokinetic/pharmacodynamic modeling of renin biomarkers in subjects treated with the renin inhibitor aliskiren. Clin Pharmacol Ther (2008) 0.78
Subjective reports of withdrawal among cocaine users: recommendations for DSM-IV. Drug Alcohol Depend (1993) 0.78
Injecting drug use, characteristics of significant others, and HIV-risk behaviors. NIDA Res Monogr (1995) 0.77
Narrowing of the drinking repertoire criterion: should it have been dropped from ICD-10? J Stud Alcohol (1995) 0.76
Reliability of drug dependents' self-reports. Drug Alcohol Depend (1998) 0.75
Re: "Cocaine use during pregnancy: perinatal outcomes". Am J Epidemiol (1992) 0.75
Patterns of drug abuse treatment utilization in a general population. NIDA Res Monogr (1990) 0.75
Cross-cultural comparison of substance abuse: results from the 12-site WHO/Study on reliability and validity. NIDA Res Monogr (1996) 0.75
Retrospective comparison of radical retropubic prostatectomy and 125iodine brachytherapy for localized prostate cancer. J Urol (1999) 0.75
The effect of questionnaire design on reported prevalence of psychoactive medication. NIDA Res Monogr (1984) 0.75
Symptom clustering of substance dependence and abuse: examining internal validity of DSM-III, and-IIIR symptom criteria. NIDA Res Monogr (1990) 0.75